|
Statements of Comprehensive Income (USD $)
In Thousands, except Share data, unless otherwise specified |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
|
Sep. 29, 2012
|
Oct. 01, 2011
|
Sep. 29, 2012
|
Oct. 01, 2011
|
|
| Net sales | $ 89 | $ 200 | $ 158 | |
| Cost of sales | (37) | (87) | (58) | |
| Gross profit | 52 | 113 | 100 | |
| Operating Expenses: | ||||
| Research and development | 676 | 483 | 1,825 | 1,304 |
| Selling, general and administrative | 745 | 711 | 2,320 | 1,952 |
| Operating loss | (1,369) | (1,194) | (4,032) | (3,156) |
| Interest income | 4 | 6 | 13 | 15 |
| Net loss | (1,365) | (1,188) | (4,019) | (3,141) |
| Basic and diluted net loss per share (in dollars per share) | $ (0.08) | $ (0.08) | $ (0.25) | $ (0.20) |
| Weighted average shares outstanding - basic and diluted (in shares) | 16,345,579 | 15,756,346 | 16,310,967 | 15,366,841 |
| Comprehensive loss | $ (1,364) | $ (1,191) | $ (4,016) | $ (3,149) |